Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10752183 | 0.85 | CYP1A2 (0.32) | CYP1A2TSHR | |
| SCHEMBL1072053 | 0.81 | CYP2A6 (0.43) | CYP1A2TSHRALDH1A1TRPA1ACHE | |
| SCHEMBL2258690 | 0.78 | HAAO (0.40) | CYP1A2ALDH1A1 | |
| SCHEMBL15352385 | 0.77 | ACHE (0.32) | ACHE | |
| SCHEMBL4161396 | 0.75 | NQO1 (0.35) | ALDH1A1 | |
| SCHEMBL1230326 | 0.74 | TSHR (0.54) | CYP1A2TSHRALDH1A1 | |
| SCHEMBL1690405 | 0.74 | — | — | |
| SCHEMBL4868173 | 0.74 | L3MBTL1 (0.38) | CYP1A2ALDH1A1ACHE | |
| SCHEMBL6217138 | 0.73 | ALDH1A1 (0.50) | CYP1A2TSHRALDH1A1TRPA1ACHE | |
| SCHEMBL3188982 | 0.73 | ALDH1A1 (0.33) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11260379-B2 | Catalysts and methods for epoxide-based polymerizations | CORNELL UNIVERSITY (US) | 2022-03-01 | — | — | US | disclosed |
| US-20200384450-A1 | CATALYSTS AND METHODS FOR EPOXIDE-BASED POLYMERIZATIONS | CORNELL UNIVERSITY | 2020-12-10 | — | — | US | disclosed |
| US-20200384450-A1 | CATALYSTS AND METHODS FOR EPOXIDE-BASED POLYMERIZATIONS | CORNELL UNIVERSITY | 2020-12-10 | — | — | US | disclosed |
| US-9944663-B2 | Process for preparing substituted pentacenes | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2018-04-17 | — | — | US | disclosed |
| US-8318048-B2 | Process for preparing substituted pentacenes | MERCK PATENT GMBH (DE) | 2012-11-27 | — | — | US | disclosed |
| US-20100127220-A1 | Process for Preparing Substituted Pentacenes | MERCK PATENT GMBH (DE) | 2010-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100127220-A1 | Process for Preparing Substituted Pentacenes | FES, PFAS, SLC46A1 | CYP1A2 1513/4885TSHR 1010/4885ALDH1A1 1737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.